极高危妊娠滋养细胞肿瘤的治疗策略

国际妇产科学杂志 ›› 2018, Vol. 45 ›› Issue (2): 216-220.

极高危妊娠滋养细胞肿瘤的治疗策略

万齐鸿，钱建华

310020 杭州，浙江大学医学院（万齐鸿）；浙江大学医学院附属第一医院妇科（钱建华）

收稿日期:2017-11-06 修回日期:2018-03-10 出版日期:2018-04-15 发布日期:2018-04-15
通讯作者: 钱建华，E-mail：qianjianhua@zju.edu.cn E-mail:345259234@qq.com
作者简介:2018-04-01

Therapeutic Strategies of Ultra High-Risk Gestational Trophoblastic Neoplasms

WAN Qi-hong，QIAN Jian-hua

Zhejiang University School of Medicine，Hangzhou 310020，China（WAN Qi-hong）；Department of Gynecology，The First Affiliated Hospital，Zhejiang University School of Medicine，Hangzhou 310003，China（QIAN Jian-hua）

Received:2017-11-06 Revised:2018-03-10 Published:2018-04-15 Online:2018-04-15
Contact: QIAN Jian-hua，E-mail：qianjianhua@zju.edu.cn E-mail:345259234@qq.com

摘要/Abstract

摘要： 妊娠滋养细胞肿瘤（GTN）是一类对化疗极敏感的恶性肿瘤，主要的治疗策略包括全身化疗和对转移瘤的处理。低危患者的总体生存率接近100%，而高危患者的总体生存率为80%～90%。国际妇产科联盟（FIGO）预后评分≥12分或存在肝、脑转移或广泛转移的患者被定义为极高危患者。极高危患者治疗效果差，死亡率高。主要原因有广泛的耐药病灶，肺部病灶进展导致呼吸衰竭以及脑、肝转移灶出血。极高危GTN患者的治疗策略以联合化疗为主，辅以手术、放疗或介入治疗等。当遇到病情严重的极高危患者时，应尽早诊断，稳定患者病情，并建议转诊至有综合诊治能力的妊娠滋养细胞疾病中心。现就极高危GTN患者的治疗策略进行综述。

关键词: 妊娠滋养细胞肿瘤, 药物疗法, 死亡, 肿瘤转移, 出血

Abstract: Gestational trophoblastic neoplasms (GTN) is a series of malignant tumor that is extremely sensitive to chemotherapy. The main therapeutic strategies include systemic chemotherapy and the treatment of metastatic tumors. The overall survival (OS) rate almost approaches 100% in low-risk patients, whereas high-risk patients can achieve a overall survival rate of 80%～90%. Patients with the FIGO prognosis score ≥12 points or those with liver, brain metastases, or extensive metastases were defined as ultra high-risk patients. Prognosis of ultra high-risk patients has been poor, and mortality rate has been high. The main reasons include widespread chemotherapy-resistant disease, respiratory failure due to progressive disease in the lungs or hemorrhage from brain and liver metastases. The therapeutic strategies for ultra high-risk GTN patients are treated primarily with combined chemotherapy, supplemented by surgery, radiotherapy or interventional therapy. It is recommended to diagnose as soon as possible and stable patient′s condition when faced with extremely serious ultra high-risk GTN patients, also referral to the gestational trophoblastic disease centres which have a comprehensive diagnosis and treatment capability. The research progress of treatment strategies for ultra high-risk GTN was discussed in this review.

Key words: Gestational trophoblastic neoplasms, Drug therapy, Death, Neoplasm metastasis, Hemorrhage

万齐鸿，钱建华. 极高危妊娠滋养细胞肿瘤的治疗策略[J]. 国际妇产科学杂志, 2018, 45(2): 216-220.

WAN Qi-hong，QIAN Jian-hua. Therapeutic Strategies of Ultra High-Risk Gestational Trophoblastic Neoplasms[J]. Journal of International Obstetrics and Gynecology, 2018, 45(2): 216-220.

参考文献

[1]Lurain JR.Gestational trophoblastic disease II:classification and management of gestational trophoblastic neoplasia[J].Am J Obstet Gynecol,204 (2011) 11–18 [2]Ngan HY,Seckl MJ,Berkowitz RS,et al.Update on the diagnosis and management of gestational trophoblastic disease[J].Int J Gynecol Obstet,131(Suppl. 2)(2015)S123–S126 [3]May T,Goldstein DP,Berkowitz RS.Current Chemotherapeutic Management of Patients with Gestational Trophoblastic Neoplasia[J]. Chemotherapy Research and Practice,Volume 2011,Article ID 806256,12 pages [4]Bolze PA,Riedl C,Massardier J,et al.Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13[J].Am J Obstet Gynecol,2016,214(3):390.e1-8 [5]Lurain JR,Singh DK,Schink JC.Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score N or = 7[J].J Reprod Med,55(2010)199–207 [6]Seckl MJ,Sebire NJ,Berkowitz RS.Gestational trophoblastic disease[J].Lancet,376(2010)717–729 (London, England) [7]Neubauer NL,Strohl AE,Lurain JR,et al.Fatal gestational trophoblastic neoplasia: An analysis of treatment failures at the Brewer Trophoblastic Disease Center from 1979–2012 compared to 1962–1978[J].Gynecol Oncol,138(2015)339–342 [8]Cyriac S,Rajendranath R,Sridevi V,et al.Etoposide, cisplatin-etoposide, methotrexate, actinomycin-D as primary treatment for management of very-high risk gestational trophoblastic neoplasia[J].Int J Gynecol Obstet,115(2011)37–39 [9]Yang J,Xiang Y,Wan X,et al.Primary treatment of stage IV gestational trophoblastic neoplasia with floxuridine，dactinomycin，etoposide and vincristine (FAEV):A report based on our 10-year clinical experiences[J].Gynecol Oncol,2016,143(1):68-72 [10]Alifrangis C,Agarwal R,Short D,et al.EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low dose etoposide-cisplatin and genetic analysis[J].Clin Oncol,31(2013) 280–286 [11]Newlands ES,Holden L,Seckl MJ,et al.Management of brain metastases in patients with high-risk gestational trophoblastic tumors[J].Reprod Med,2002 Jun;47(6):465-71 [12]Evans Jr AC,Soper JT,Clarke-Pearson DL,et al.Gestational trophoblastic disease metastatic to the central nervous system[J].Gynecol Oncol,1995;59:226–230 [13]Schechter NR,Mychalczak B,Jones W,et al.Prognosis of patients treated with whole-brain radiation therapy for metastatic gestational trophoblastic disease[J].Gynecol Oncol,1998,68(2):183-192 [14]陈晨,向阳.选择性肝动脉插管治疗滋养细胞肿瘤肝转移8例[J].新医学,2000;31(9):540-541 [15]Barnard DE,Woodward KT,Yancy SG,et al.Hepatic metastases of choriocarcinoma:A report of 15 patients[J].Gynecol Oncol,1986;25:73–83 [16]El-Helw LM,Hancock BW.Treatment of metastatic gestational trophoblastic neoplasia[J].Lancet Oncol,2007;8:715–24